Recombinant adenoviral TRIM21 (Ad-Trim21) infection of mice increased hepatic TRIM21 expression to levels similar as those observed in mice on HFD or NASH diets (Figure 2, A–C; Figure 4A; and Supplemental Figure 4A). Here, TRIM21 is linked to metabolic dysfunction-associated steatohepatitis.